Apollon Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
6,572
-31
-0.5% -$6.08K 0.02% 608
2026
Q1
$1.29M Sell
6,603
-507
-7% -$98.5K 0.02% 509
2025
Q4
$1.23M Buy
7,110
+376
+6% +$68.5K 0.02% 505
2025
Q3
$1.28M Buy
6,734
+358
+6% +$63.5K 0.02% 498
2025
Q2
$1.15M Sell
6,376
-292
-4% -$50.7K 0.02% 515
2025
Q1
$1.13M Buy
6,668
+345
+5% +$56.7K 0.02% 476
2024
Q4
$954K Buy
6,323
+44
+0.7% +$6.84K 0.02% 531
2024
Q3
$975K Sell
6,279
-732
-10% -$109K 0.03% 504
2024
Q2
$960K Buy
7,011
+1,293
+23% +$177K 0.03% 485
2024
Q1
$761K Sell
5,718
-850
-13% -$110K 0.02% 546
2023
Q4
$906K Buy
6,568
+1,823
+38% +$240K 0.03% 482
2023
Q3
$578K Buy
4,745
+126
+3% +$16.8K 0.03% 513
2023
Q2
$649K Sell
4,619
-86
-2% -$11.9K 0.03% 528
2023
Q1
$666K Sell
4,705
-109
-2% -$15.6K 0.04% 443
2022
Q4
$753K Buy
4,814
+78
+2% +$11.2K 0.05% 382
2022
Q3
$581K Sell
4,736
-25
-0.5% -$3.29K 0.05% 406
2022
Q2
$633K Buy
+4,761
New +$649K 0.05% 374

Other funds holding DGX

Apollon Wealth Management's DGX Position: Q2 2026 in Review

Apollon Wealth Management reduced its Quest Diagnostics (DGX) stake by 0.47% in Q2 2026, selling an estimated $6.08K and leaving 6,572 shares worth $1.39M. The position accounts for 0.02% of the portfolio, ranked #608.

Apollon Wealth Management first reported a position in DGX in Q2 2022 and has held it in 17 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Apollon Wealth Management held 6,572 shares of Quest Diagnostics worth $1.39M as of Q2 2026.
  • Apollon Wealth Management sold 31 Quest Diagnostics shares in Q2 2026, an estimated $6.08K.
  • Quest Diagnostics made up 0.02% of Apollon Wealth Management's portfolio in Q2 2026, its #608 holding.
  • Apollon Wealth Management first reported a position in Quest Diagnostics in Q2 2022 and has held it in 17 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.